Johnson & JohnsonJNJ
NYSE•Healthcare•Drug Manufacturers - General
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $96.36B, growing 7.9% year-over-year. TTM net income stood at $21.04B (3.5% contraction). Quarterly EBITDA was $8.41B and operating income was $6.41B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze JNJ growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters